Eden Research (LON:EDEN) Hits New 52-Week Low – What’s Next?

Eden Research plc (LON:EDEN) hit a new 52-week low on Wednesday . The stock traded as low as GBX 2.90 ($0.04) and last traded at GBX 2.90 ($0.04), with a volume of 258375 shares. The stock had previously closed at GBX 2.95 ($0.04).

Eden Research Trading Down 5.1 %

The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80. The stock has a market capitalization of £14.93 million, a PE ratio of -9.81 and a beta of 0.92. The business’s 50-day moving average is GBX 3.54 and its two-hundred day moving average is GBX 3.79.

Insider Activity

In other Eden Research news, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($28,036.31). Also, insider Lykele van der Broek purchased 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The stock was acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($13,278.01). Insiders have bought a total of 964,487 shares of company stock valued at $3,690,001 over the last quarter. Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.